SCHEMBL570068

SCHEMBL570068

NNN1C(=O)CCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4948829 0.73
SCHEMBL16129944 0.69
SCHEMBL20111621 0.69
SCHEMBL9749302 0.69
SCHEMBL7635569 0.69
SCHEMBL8380249 0.67 KDM4E (0.37)
SCHEMBL7658475 0.65
SCHEMBL11527806 0.65 KDM4E (0.48)
SCHEMBL16051806 0.65
SCHEMBL7658483 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110373405-A A kind of biological enzyme of graft polymers and preparation method thereof and fixing means 西安理工大学 2019-10-25 CN claimed
CN-114206934-A Encapsulated protein-6 bispecific antibodies 加利福尼亚大学董事会 2022-03-18 CN disclosed
CN-114174340-A Encapsulated protein-6 antibodies and drug conjugates 加利福尼亚大学董事会 2022-03-11 CN disclosed
CN-113194985-A EpCAM antibodies, activatable antibodies and immunoconjugates and uses thereof 伊缪诺金公司 2021-07-30 CN disclosed
US-20170152288-A1 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY NOVALIX DEUTSCHLAND GMBH (DE) 2017-06-01 US disclosed
EP-3065780-A1 ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES Pfizer Inc. (US) 2016-09-14 EP disclosed
US-9125847-B2 A-β immunogenic peptide carrier conjugates and methods of producing same JANSSEN SCIENCES IRELAND UC (IE) 2015-09-08 US disclosed
US-9089510-B2 A-β immunogenic peptide carrier conjugates and methods of producing same JANSSEN SCIENCES IRELAND UC (IE) 2015-07-28 US disclosed
EP-2298736-B1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents SOLULINK INC (US) 2015-07-15 EP disclosed
WO-2015065954-A1 ANTI-EFNA4 ANTIBODY-DRUG CONJUGATES PFIZER, INC. (US) 2015-05-07 WO disclosed
EP-1752516-A1 Dispersants The Lubrizol Corporation (US) 2007-02-14 EP disclosed
US-20070027046-A1 Novel Dispersants THE LUBRIZOL CORPORATION (US) 2007-02-01 US disclosed
US-6800728-B2 CROSSLINKING AND IMMOBILIZING BIOMOLECULES, DRUGS AND SYNTHETIC POLYMERS WITH A THIOL OR AMINO REACTIVE GROUP AND HYDRAZINO OR OXYAMINO MOIETIES SOLULINK BIOSCIENCES, INC. 2004-10-05 US disclosed
US-20040110730-A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents AUDAX PRIVATE DEBT LLC, AS AGENT 2004-06-10 US disclosed
US-20030199466-A1 For modulating an immune response DYNAVAX TECHNOLOGIES CORPORATION 2003-10-23 US disclosed
EP-1315699-A2 HYDRAZINE-BASED AND CARBONYL-BASED BIFUNCTIONAL CROSSLINKING REAGENTS Solulink, Incorporated (US) 2003-06-04 EP disclosed
US-20030013857-A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents SOLULINK INCORPORATED 2003-01-16 US disclosed
US-20020119095-A1 Chemotherapeutic agents conjugated to p97 and their methods of use in treating neurological tumours GABATHULER REINHARD (CA) 2002-08-29 US disclosed
WO-2002013843-A2 CHEMOTHERAPEUTIC AGENTS CONJUGATED TO P97 AND THEIR METHODS OF USE IN TREATING NEUROLOGICAL TUMOURS UNIVERSITY OF BRITISH COLUMBIA (CA) 2002-02-21 WO disclosed
WO-2001070685-A2 HYDRAZINE-BASED AND CARBONYL-BASED BIFUNCTIONAL CROSSLINKING REAGENTS SOLULINK, INCORPORATED (US) 2001-09-27 WO disclosed